⌘K

Login Start Free

Home/Filings/4/0001209191-19-060662

4//SEC Filing

Yanni Barbara 4

Accession 0001209191-19-060662

CIK 0001662524other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:35 PM ET

Size

5.3 KB

Accession

0001209191-19-060662

Insider Transaction Report

Form 4

Period: 2019-12-13

AKCEA THERAPEUTICS, INC.AKCA

Director

Transactions

Award
Stock Option (right to buy)
2019-12-13+53,000→ 53,000 total
Exercise: $19.30Exp: 2029-12-12→ Common Stock (53,000 underlying)

Footnotes (1)

[F1]The shares vest over a four year period in equal annual installments beginning on December 13, 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AKCEA THERAPEUTICS, INC.

CIK 0001662524

Entity typeother

Related Parties

1

filerCIK 0001610561

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 4:35 PM ET
Size: 5.3 KB

View on SEC.gov